全文获取类型
收费全文 | 3329篇 |
免费 | 155篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 52篇 |
儿科学 | 62篇 |
妇产科学 | 155篇 |
基础医学 | 552篇 |
口腔科学 | 80篇 |
临床医学 | 239篇 |
内科学 | 740篇 |
皮肤病学 | 61篇 |
神经病学 | 487篇 |
特种医学 | 178篇 |
外科学 | 368篇 |
综合类 | 14篇 |
一般理论 | 2篇 |
预防医学 | 148篇 |
眼科学 | 33篇 |
药学 | 201篇 |
中国医学 | 2篇 |
肿瘤学 | 129篇 |
出版年
2023年 | 23篇 |
2022年 | 52篇 |
2021年 | 90篇 |
2020年 | 40篇 |
2019年 | 64篇 |
2018年 | 78篇 |
2017年 | 56篇 |
2016年 | 61篇 |
2015年 | 91篇 |
2014年 | 105篇 |
2013年 | 114篇 |
2012年 | 210篇 |
2011年 | 277篇 |
2010年 | 139篇 |
2009年 | 134篇 |
2008年 | 214篇 |
2007年 | 202篇 |
2006年 | 203篇 |
2005年 | 177篇 |
2004年 | 156篇 |
2003年 | 135篇 |
2002年 | 119篇 |
2001年 | 22篇 |
2000年 | 16篇 |
1999年 | 23篇 |
1998年 | 14篇 |
1997年 | 18篇 |
1996年 | 13篇 |
1995年 | 19篇 |
1994年 | 14篇 |
1992年 | 12篇 |
1991年 | 10篇 |
1990年 | 15篇 |
1933年 | 17篇 |
1932年 | 20篇 |
1931年 | 14篇 |
1930年 | 16篇 |
1928年 | 15篇 |
1923年 | 12篇 |
1922年 | 13篇 |
1911年 | 9篇 |
1909年 | 11篇 |
1908年 | 18篇 |
1907年 | 17篇 |
1906年 | 14篇 |
1905年 | 12篇 |
1904年 | 9篇 |
1903年 | 9篇 |
1902年 | 13篇 |
1880年 | 11篇 |
排序方式: 共有3503条查询结果,搜索用时 15 毫秒
31.
Schmidt J Ryschich E Sinn HP Maksan S Herfarth C Klar E 《Digestive diseases and sciences》1999,44(4):823-829
The levels of trypsinogen activation peptides(TAP) were quantified by ELISA immunoassay in acutepancreatitis of the rat and compared to the degree oflate histopathological sequelae and exocrine functional impairment 4 and 12 weeks after the acute phaseof the disease. For this purpose acute pancreatitis ofdifferent severity was induced using a suitable ratmodel recently described. Forty five surviving animals were studied. The level of TAP inperitoneal exudate measured 3 and 6 hr afterpancreatitis induction correlated well with the amountof the late histopathological injury at the end of thecorresponding observation period (at 4 weeks after 3 hr: r =0.75, P = 0.003, after 6 hr: r = 0.72, P = 0.005,Pearson; and at 12 weeks after 3 hr: r = 0.86, P =0.0001, after 6 hr: r = 0.84, P = 0.0001, Pearson). A negative correlation of TAP with the impairmentof exocrine function was found only at 4 weeks for thesecretion of total protein (r = –0.76 after 3 hr;r = –0.62 after 6 hr) and for exocrine function (r = –0.67 after 3 hr, r = –0.57 after6 hr), but not at 12 weeks after acute pancreatitis. Nocorrelation with plasma amylase and lipase was found. Weconclude that quantitation of TAP in ascites provides an accurate prediction of late histopathologicsequelae. Pancreatic exocrine function could bepredicted by TAP assay only in the early stage afterpancreatitis induction (eg, four weeks). In later stages of the disease (eg, 12 weeks) remainingpancreatic tissue seems to compensate for any exocrinedeficits that have occurred. 相似文献
32.
33.
Svetlana Fischer Nancy Agmon-Levin Yinon Shapira Bat-Sheva Porat Katz Eduard Graell Ricard Cervera Ljudmila Stojanovich Jose A. Gómez Puerta Raimon Sanmartí Yehuda Shoenfeld 《Immunologic research》2013,56(2-3):287-292
Parasitic infections may induce variable immunomodulatory effects and control of autoimmune disease. Toxoplasma gondii (T. gondii) is a ubiquitous intracellular protozoan that was recently associated with autoimmunity. This study was undertaken to investigate the seroprevalence and clinical correlation of anti-T. gondii antibodies in patients with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). We evaluated sera from European patients with RA (n = 125) and SLE (n = 164) for the prevalence of anti-T. gondii IgG antibodies (ATXAb), as well as other common infections such as Cytomegalovirus, Epstein-Barr, and Rubella virus. The rates of seropositivity were determined utilizing the LIAISON chemiluminescent immunoassays (DiaSorin, Italy). Our results showed a higher seroprevalence of ATXAb in RA patients, as compared with SLE patients [63 vs. 36 %, respectively (p = 0.01)]. The rates of seropositivity of IgG against other infectious agents were comparable between RA and SLE patients. ATXAb-seropositivity was associated with older age of RA patients, although it did not correlate with RA disease activity and other manifestations of the disease. In conclusion, our data suggest a possible link between exposure to T. gondii infection and RA. 相似文献
34.
Alba Tristán-Noguero PhD Eva Borràs PhD Marta Molero-Luis PhD Tessa Wassenberg MD PhD Tessa Peters MSc Marcel M. Verbeek PhD Michel Willemsen MD PhD Thomas Opladen MD PhD Kathrin Jeltsch PhD Roser Pons MD PhD Beat Thony PhD Gabriella Horvath MD Zuhal Yapici MD Jennifer Friedman MD Keith Hyland PhD Guillermo E. Agosta MD Eduardo López-Laso MD Rafael Artuch MD PhD Eduard Sabidó PhD Àngels García-Cazorla MD PhD 《Movement disorders》2021,36(3):690-703
35.
36.
37.
Alicia Calvo-Fernández Andrea Izquierdo Isaac Subirana Nuria Farré Joan Vila Xavier Durán Marcos García-Guimaraes Sandra Valdivielso Paula Cabero Cristina Soler Cora García-Ribas Clara Rodríguez Marc Llagostera Diana Mojón Miren Vicente Eduard Solé-González Andrea Sánchez-Carpintero Cristina Tevar Beatriz Vaquerizo 《Revista espa?ola de cardiología》2021,74(7):576-583
Introduction and objectivesCOVID-19 is currently causing high mortality and morbidity worldwide. Information on cardiac injury is scarce. We aimed to evaluate cardiovascular damage in patients with COVID-19 and determine the correlation of high-sensitivity cardiac-specific troponin T (hs-cTnT) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) with the severity of COVID-19.MethodsWe included 872 consecutive patients with confirmed COVID-19 from February to April 2020. We tested 651 patients for high-sensitivity troponin T (hs-TnT) and 506 for NT-proBNP on admission. Cardiac injury was defined as hs-TnT > 14 ng/L, the upper 99th percentile. Levels of NT-proBNP > 300 pg/mL were considered related to some extent of cardiac injury. The primary composite endpoint was 30-day mortality or mechanical ventilation (MV).ResultsCardiac injury by hs-TnT was observed in 34.6% of our COVID-19 patients. Mortality or MV were higher in cardiac injury than noncardiac injury patients (39.1% vs 9.1%). Hs-TnT and NT-proBNP levels were independent predictors of death or MV (HR, 2.18; 95%CI, 1.23-3.83 and 1.87 (95%CI, 1.05-3.36), respectively) and of mortality alone (HR, 2.91; 95%CI, 1.211-7.04 and 5.47; 95%CI, 2.10-14.26, respectively). NT-ProBNP significantly improved the troponin model discrimination of mortality or MV (C-index 0.83 to 0.84), and of mortality alone (C-index 0.85 to 0.87).ConclusionsMyocardial injury measured at admission was a common finding in patients with COVID-19. It reliably predicted the occurrence of mortality and need of MV, the most severe complications of the disease. NT-proBNP improved the prognostic accuracy of hs-TnT. 相似文献
38.
Eduard Tornero Sebastian García-Ramiro Juan C. Martínez-Pastor Guillem Bori Jordi Bosch Laura Morata Marta Sala Misericordia Basora Josep Mensa Alex Soriano 《Antimicrobial agents and chemotherapy》2015,59(2):831-837
The aim of this study was to compare the prosthetic joint infection (PJI) rate after total joint arthroplasty in two consecutive periods of treatment with different antibiotic prophylaxes: cefuroxime versus cefuroxime plus teicoplanin. We retrospectively reviewed 1,896 patients who underwent total hip arthroplasty or total knee arthroplasty between March 2010 and February 2013. From March 2010 to August 2011, patients received 1.5 g of cefuroxime during induction of anesthesia and another 1.5 g 2 h later (the C group). From September 2011, 800 mg of teicoplanin was added to cefuroxime (the CT group). Throughout the period studied, there were no variations in pre- or postoperative protocols. Univariate and multivariate analyses were performed to evaluate independent predictors of PJI. There were 995 (55.7%) patients in the C group and 791 (44.3%) in the CT group. Patients in the CT group had a significantly lower PJI rate than patients in the C group (1.26% versus 3.51%, P = 0.002). There were no infections due to Staphylococcus aureus in the CT group (0% versus 1.6% in the C group, P < 0.001). A stepwise forward Cox regression model identified male sex (hazard ratio [HR], 3.85; 95% confidence interval [CI], 2.09 to 7.18), a body mass index of ≥35 kg/m2 (HR, 2.93; 95% CI, 1.37 to 6.27), the presence of lung disease (HR, 2.46; 95% CI, 1.17 to 5.15), and red blood cell transfusion (HR, 3.70; 95% CI, 1.89 to 7.23) to be independent variables associated with a higher risk of PJI. The addition of teicoplanin was associated with a lower risk of infection (HR, 0.35; 95% CI, 0.17 to 0.74). In conclusion, the addition of teicoplanin to cefuroxime during primary arthroplasty was associated with a significant reduction in the global PJI rate due to a reduction of infections caused by Gram-positive bacteria. 相似文献
39.
40.
Jaume Miranda-Rius Lluís Brunet-Llobet Eduard Lahor-Soler Magí Farré 《International journal of medical sciences》2015,12(10):811-824
Background: Salivary secretory disorders can be the result of a wide range of factors. Their prevalence and negative effects on the patient''s quality of life oblige the clinician to confront the issue.Aim: To review the salivary secretory disorders, inducing drugs and their clinical management.Methods: In this article, a literature search of these dysfunctions was conducted with the assistance of a research librarian in the MEDLINE/PubMed Database.Results: Xerostomia, or dry mouth syndrome, can be caused by medication, systemic diseases such as Sjögren''s Syndrome, glandular pathologies, and radiotherapy of the head and neck. Treatment of dry mouth is aimed at both minimizing its symptoms and preventing oral complications with the employment of sialogogues and topical acting substances. Sialorrhea and drooling, are mainly due to medication or neurological systemic disease. There are various therapeutic, pharmacologic, and surgical alternatives for its management. The pharmacology of most of the substances employed for the treatment of salivary disorders is well-known. Nevertheless, in some cases a significant improvement in salivary function has not been observed after their administration.Conclusion: At present, there are numerous frequently prescribed drugs whose unwanted effects include some kind of salivary disorder. In addition, the differing pathologic mechanisms, and the great variety of existing treatments hinder the clinical management of these patients.The authors have designed an algorithm to facilitate the decision making process when physicians, oral surgeons, or dentists face these salivary dysfunctions. 相似文献